A/Prof James Wells
The University of Queensland, Australia

Associate Professor James Wells leads the Novel Cancer Therapeutics Group at Frazer Institute and is the Director of Immunology at the Dermatology Research Centre, University of Queensland. He is also the Vice President of the Molecular and Experimental Pathology Society of Australasia (MEPSA), and a mentee of the Australian Academy of Health and Medical Sciences (AAHMS). He received his PhD in cancer immunotherapy from King's College London, UK, and postdoctoral training at Harvard Medical School, USA, where he received an award for research excellence and was promoted to Faculty as an Instructor. Since 2011, he has led a research team at the University of Queensland’s Frazer Institute investigating novel treatments for squamous cell carcinoma. In collaboration with the Queensland Emory Drug Discovery Initiative, he has recently developed and patented a drug (Q2361) designed to prevent and treat skin cancer in immune-suppressed solid organ transplant recipients.